‘Formal review’ of GP access arrangements needed, says Healthwatch
UK-based charity conducted a review of GP access between April 2019 and December 2020
22nd March 2021
UK-based charity conducted a review of GP access between April 2019 and December 2020
22nd March 2021
Kyprolis plus lenalidomide and dexamethasone approved as a second-line treatment
22nd March 2021
Tecentriq is approved in five lung cancer indications currently
22nd March 2021
On the client side, AstraZeneca came out on top with four Golds, one Silver and one Bronze awards
19th March 2021
PCR-based test has a sample collection to result time of 25 minutes
19th March 2021
EP0042 is a dual-inhibitor drug designed to block the activity of two cancer-driving proteins
19th March 2021
Genomic HRD testing to be launched to support the introduction of this treatment regimen
19th March 2021
MHRA and EMA conclude the vaccine's benefits continue to outweigh risks
19th March 2021
GSK’294 is designed to deliver long-acting suppression of IL-5 in severe eosinophilic asthma patients
18th March 2021
In the UK, over seven million people are affected by cardiovascular disease
18th March 2021
Recommendation offers new chemotherapy-free treatment options for these patients
18th March 2021
Hubs will be located at King’s College London, NHS Blood and Transplant in Bristol and the University of Sheffield
18th March 2021
Cushing's Syndrome is rare and severe condition caused by prolonged high levels of cortisol in the blood
17th March 2021
Belzutifan is a potential treatment for von Hippel-Lindau disease-associated renal cell carcinoma
17th March 2021
Patients treated with monoclonal antibody achieved clinical remission at week 12
17th March 2021